Critical Role for Cold Shock Protein YB-1 in Cytokinesis.
YB-1
atomistic modelling
cold shock protein
confocal microscopy
cytokinesis
live-cell imaging
phosphorylation
post-translational modification
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
01 Sep 2020
01 Sep 2020
Historique:
received:
10
07
2020
revised:
21
08
2020
accepted:
27
08
2020
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
5
9
2020
Statut:
epublish
Résumé
High levels of the cold shock protein Y-box-binding protein-1, YB-1, are tightly correlated with increased cell proliferation and progression. However, the precise mechanism by which YB-1 regulates proliferation is unknown. Here, we found that YB-1 depletion in several cancer cell lines and in immortalized fibroblasts resulted in cytokinesis failure and consequent multinucleation. Rescue experiments indicated that YB-1 was required for completion of cytokinesis. Using confocal imaging we found that YB-1 was essential for orchestrating the spatio-temporal distribution of the microtubules, β-actin and the chromosome passenger complex (CPC) to define the cleavage plane. We show that phosphorylation at six serine residues was essential for cytokinesis, of which novel sites were identified using mass spectrometry. Using atomistic modelling we show how phosphorylation at multiple sites alters YB-1 conformation, allowing it to interact with protein partners. Our results establish phosphorylated YB-1 as a critical regulator of cytokinesis, defining precisely how YB-1 regulates cell division.
Identifiants
pubmed: 32882852
pii: cancers12092473
doi: 10.3390/cancers12092473
pmc: PMC7565962
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : James Cook Fellowship
ID : JCF-UOO1501
Organisme : Cancer Society New Zealand
ID : 11/07
Organisme : Health Research Council A*STAR
ID : 10-02
Organisme : Health Research Council, NZ
ID : 15/500
Organisme : Cancer Institute NSW
ID : 05/FRL/1-01
Organisme : Australian NHMRC
ID : 1106241
Organisme : Cancer Institute NSW
ID : 11/FRL/5-02
Références
Sci Rep. 2018 Oct 24;8(1):15726
pubmed: 30356079
Cancer Res. 1991 Aug 1;51(15):4090-6
pubmed: 1855224
J Biol Chem. 2017 Feb 24;292(8):3433-3444
pubmed: 28077578
Mol Cell Biochem. 2017 Sep;433(1-2):1-12
pubmed: 28382490
Anal Chem. 1996 Mar 1;68(5):850-8
pubmed: 8779443
J Mol Biol. 2002 Feb 15;316(2):317-26
pubmed: 11851341
J Biol Chem. 2016 Jun 3;291(23):12145-60
pubmed: 27080258
Oncogene. 2009 Jun 25;28(25):2406-18
pubmed: 19430491
Cancer Res. 2005 May 15;65(10):4078-87
pubmed: 15899797
Nucleic Acids Res. 2018 Jan 9;46(1):104-119
pubmed: 29059375
Exp Cell Res. 2016 Aug 15;346(2):157-66
pubmed: 27397581
Int J Cell Biol. 2009;2009:243532
pubmed: 20414334
Front Cell Dev Biol. 2019 Oct 01;7:221
pubmed: 31632972
Cancer Res. 2008 Nov 1;68(21):8661-6
pubmed: 18974106
Eur J Cancer. 2010 Mar;46(5):954-65
pubmed: 20079629
BMC Biochem. 2008 Sep 15;9:23
pubmed: 18793384
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Anticancer Res. 2017 Apr;37(4):1603-1608
pubmed: 28373420
Protein Eng Des Sel. 2011 Mar;24(3):255-60
pubmed: 21062758
Genes Dev. 2017 Jan 1;31(1):34-45
pubmed: 28130345
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Nat Protoc. 2006;1(4):1929-35
pubmed: 17487178
Nephron Exp Nephrol. 2011;118(4):e100-8
pubmed: 21372592
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Mol Cell Biol. 2005 Jun;25(11):4625-37
pubmed: 15899865
Cell. 2008 Feb 8;132(3):487-98
pubmed: 18267078
Biochem J. 2013 Jan 1;449(1):11-23
pubmed: 23216250
J Mol Model. 2006 Feb;12(3):281-9
pubmed: 16240095
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15209-14
pubmed: 8986789
Breast Cancer Res. 2008;10(5):R86
pubmed: 18925950
Nature. 1988 Jul 14;334(6178):124-9
pubmed: 2968522
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4563-5
pubmed: 291988
Pac Symp Biocomput. 2009;:504-15
pubmed: 19209726
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Elife. 2013 Sep 10;2:e00683
pubmed: 24040511
Science. 2014 Oct 10;346(6206):244-7
pubmed: 25301629
J Biol Chem. 2003 Sep 12;278(37):35516-23
pubmed: 12835324
BMC Bioinformatics. 2008 Jan 23;9:40
pubmed: 18215316
Oncotarget. 2017 Jul 18;8(29):48110-48125
pubmed: 28624808
Prostate. 2014 Jun;74(9):959-69
pubmed: 24740858
Biochemistry (Mosc). 2011 Dec;76(13):1402-33
pubmed: 22339596
Mol Cancer Ther. 2009 Dec;8(12):3276-84
pubmed: 19996271
J Biol Chem. 2006 Dec 29;281(52):40440-9
pubmed: 17082189
Genes Cells. 2005 Feb;10(2):127-37
pubmed: 15676024
J Biol Chem. 1996 Apr 12;271(15):8556-63
pubmed: 8621482
Exp Cell Res. 2018 Feb 1;363(1):95-101
pubmed: 29289594
Int J Cancer. 2016 Sep 1;139(5):1157-70
pubmed: 27072400
Cold Spring Harb Perspect Biol. 2015 Feb 13;7(4):a015834
pubmed: 25680833
Development. 2018 Oct 2;145(19):
pubmed: 30135188
Nat Rev Mol Cell Biol. 2012 Dec;13(12):789-803
pubmed: 23175282
Nat Methods. 2007 Nov;4(11):923-5
pubmed: 17952086
Oncogene. 2011 Aug 25;30(34):3649-60
pubmed: 21423216
Mol Biol Cell. 2017 Dec 1;28(25):3634-3646
pubmed: 28954866
J Cell Sci. 2014 Feb 1;127(Pt 3):534-45
pubmed: 24284076
Wiley Interdiscip Rev Dev Biol. 2015 Sep-Oct;4(5):469-87
pubmed: 25827130
PLoS One. 2011;6(6):e20603
pubmed: 21695211
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Oncogene. 2005 Dec 15;24(56):8314-25
pubmed: 16158057
Breast Cancer Res. 2007;9(5):R61
pubmed: 17875215
J Biol Chem. 2003 Jul 25;278(30):27988-96
pubmed: 12695516
Mol Cell Biol. 2006 Jan;26(1):277-92
pubmed: 16354698
Genes (Basel). 2018 Oct 22;9(10):
pubmed: 30360431
Nat Rev Genet. 2007 Jul;8(7):533-43
pubmed: 17572691
Eur Biophys J. 2005 Dec;35(1):40-52
pubmed: 16184388
Breast Cancer Res. 2008;10(6):R99
pubmed: 19036157
Drug Des Devel Ther. 2019 Jan 14;13:317-326
pubmed: 30679904
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Int J Mol Sci. 2018 Aug 18;19(8):
pubmed: 30126195
Acta Biochim Biophys Sin (Shanghai). 2020 Feb 3;52(2):168-179
pubmed: 32047913
Oncogene. 2010 Jan 21;29(3):403-10
pubmed: 19838214
Oncotarget. 2015 Oct 6;6(30):29396-412
pubmed: 26318844
Oncogene. 2005 Jun 16;24(26):4281-92
pubmed: 15806160
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
J Natl Cancer Inst. 2012 Jan 18;104(2):133-46
pubmed: 22205655
Cell. 2014 Aug 14;158(4):833-848
pubmed: 25126788
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Oncotarget. 2013 Feb;4(2):329-45
pubmed: 23593654
Int J Cancer. 2007 May 15;120(10):2110-8
pubmed: 17266041
J RNAi Gene Silencing. 2009 Mar 09;5(1):321-30
pubmed: 19771229
Cancers (Basel). 2020 Jan 29;12(2):
pubmed: 32013098
Nat Med. 1997 Apr;3(4):447-50
pubmed: 9095180
J Mol Cell Biol. 2014 Aug;6(4):272-85
pubmed: 24924767
Oncotarget. 2017 Jan 10;8(2):2604-2616
pubmed: 27911878